LH · News · 20260809N

Regulatory Approval Milestones

LABCORP HOLDINGS INC. · 2026-08-09 · Importance 41 · Surprise 60

Labcorp announced nationwide availability of Roche's VENTANA PTEN (SP218) RxDx Assay. The assay is FDA-approved and supports prostate-cancer diagnostics, precision oncology, and personalized cancer care. The report identifies reimbursement pressure and competitive pricing as continuing risks to the commercial opportunity.